Travere Therapeutics TVTX
NASDAQ TVTX
$52.92 +0.63 (+1.20%)
As of: Oct 21, 2026 · 2:51 PM EDT

Travere Therapeutics (TVTX) Current Taxes (2015 - 2017)

Updated

Travere Therapeutics (TVTX) recorded Current Taxes of $1.15 million in Q3 2017, down 70.3% from $3.88 million a year earlier.

Analysis

Travere Therapeutics (TVTX) Current Taxes (2015 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn -
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 1.05 Bn
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn -
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 1.47 Bn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn -
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn 653.00 Mn
10 Travere Therapeutics 4.95 Bn 4.55 Bn 167.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 1.15 Mn
Sep 30, 2016 3.88 Mn
Sep 30, 2015 9.63 Mn
API Access

Travere Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=TVTX&period=max&api_key=YOUR_API_KEY